InsmedNasdaq: INSM: Global biopharmaceutical developing therapies for serious, rare diseases.
10+ YOEPhD in a quantitative discipline and ~10 years in computational biology; deep expertise in computational protein design and deep learning; proven team leadership and collaboration with experimental scientists; experience with data analysis and infrastructure.